KAYLA WILT: Open Payments
NPI 1629685995 · BEDFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 57 payments from 15 companies in 2025. Trend: 2023 $452 · 2024 $935 · 2025 $896
Food & beverage: $863Education: $32
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $229 |
| ABBVIE INC. | 14 | $165 |
| Lilly USA, LLC | 11 | $153 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $43 |
| PFIZER INC. | 2 | $39 |
| Indivior Inc. | 2 | $34 |
| CeQur Corporation | 1 | $31 |
| Xeris Pharmaceuticals, Inc. | 2 | $30 |
| GlaxoSmithKline, LLC. | 1 | $29 |
Products named: VRAYLAR, Wegovy, ZEPBOUND, MOUNJARO, MAVYRET, CAPLYTA, Kerendia, NURTEC ODT.
Industry payments across PA — which companies pay providers there.
